- Report
- September 2022
- 181 Pages
Asia Pacific
From €3070EUR$3,450USD£2,702GBP
- Report
- September 2022
- 127 Pages
North America
From €3070EUR$3,450USD£2,702GBP
- Report
- August 2022
- 104 Pages
From €3070EUR$3,450USD£2,702GBP
- Report
- August 2022
- 112 Pages
Middle East, Africa
From €3070EUR$3,450USD£2,702GBP
- Report
- August 2022
- 124 Pages
Asia Pacific
From €3070EUR$3,450USD£2,702GBP
- Report
- July 2022
- 120 Pages
North America
From €3070EUR$3,450USD£2,702GBP
- Report
- July 2022
- 132 Pages
Europe
From €3070EUR$3,450USD£2,702GBP
- Report
- July 2022
- 122 Pages
United Kingdom
From €3070EUR$3,450USD£2,702GBP
- Report
- March 2022
- 198 Pages
Global
From €3960EUR$4,450USD£3,486GBP
- Report
- February 2022
- 174 Pages
Global
From €3960EUR$4,450USD£3,486GBP
- Report
- August 2024
- 135 Pages
Global
From €3515EUR$3,950USD£3,094GBP
- Report
- August 2024
- 110 Pages
Global
From €3515EUR$3,950USD£3,094GBP
- Report
- May 2024
- 130 Pages
Global
From €3515EUR$3,950USD£3,094GBP
- Report
- April 2024
- 121 Pages
Global
From €3515EUR$3,950USD£3,094GBP
- Report
- April 2024
- 120 Pages
Global
From €3782EUR$4,250USD£3,329GBP
- Report
- November 2023
- 146 Pages
Global
From €3960EUR$4,450USD£3,486GBP
- Report
- January 2023
- 132 Pages
Global
From €3960EUR$4,450USD£3,486GBP
- Report
- December 2022
- 142 Pages
Global
From €3960EUR$4,450USD£3,486GBP
- Report
- December 2019
- 120 Pages
Global
From €3292EUR$3,700USD£2,898GBP
- Report
- July 2025
- 200 Pages
India
From €2482EUR$2,789USD£2,185GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more